COURTNEY SNYDER: Open Payments
NPI 1316114259 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 13 payments from 11 companies in 2025. Trend: 2023 $134 · 2024 $241 · 2025 $324
Food & beverage: $281Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $69 |
| Janssen Biotech, Inc. | 2 | $38 |
| Blueprint Medicines Corporation | 1 | $34 |
| Lilly USA, LLC | 1 | $28 |
| ABBVIE INC. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Myriad Genetic Laboratories, Inc. | 1 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $21 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
Products named: ENHERTU, AYVAKIT, VERZENIO, ELAHERE, KEYTRUDA, MYRISK, TAVALISSE, CARVYKTI.
Industry payments across AZ — which companies pay providers there.
